← Leaderboards
Yvonne Marie Mowery
Duke University
$1,022,685
Attributed
$1,241,310
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $359.6K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,241,310 · 2
By mechanism
K08$804,060 · 1
R21$437,250 · 1
Top collaborators
- Nicole N Scheff2 shared
Most similar at Duke University
Same institution · by research overlap
- Sheila Collins$15,347,398
- Nosayaba Osazuwa-Peters$3,060,995
- Matthew J Wolf$7,663,961
- Michael D Ehlers$9,029,218
- Kyle Lafata$1,922,056
Others in their field
Other Emerging Leaders on “Radiation Response”
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Kevin Michael Tuohey · Boston University Medical Campus$9,603,543
- Ashlee Fitch · Steelworker Charitable/Educational Org$9,472,828
- Zachary Scott Morris · University Of Wisconsin-Madison$7,170,916
- Gordon M Ringold · Quadriga Biosciences, Inc.$6,041,839
- Aaron D Finke · Cornell University$5,853,775
Research focus
Radiation ResponseCancer TherapyMalignant Mouth NeoplasmPre-Clinical ModelStandard Of CareRadiation TherapyHead And Neck CancerLesionMouse ModelPre-ClinicalRecurrenceResponseTumorTumor MicroenvironmentAffectDoseHead And Neck Cancer PatientCancer CellCancer ModelMalignant NeoplasmsNovel TherapeuticsClinical TrialsCombined Modality TherapyCompetence
Grant awards (7)
Targeting TRPV1-containing nerves for radiation-induced pain and oral mucositis$238,500
R21 · FY2025 · DE
Targeting TRPV1-containing nerves for radiation-induced pain and oral mucositis$198,750
R21 · FY2024 · DE
Employing Novel Primary Mouse Models of Head and Neck Cancer to Overcome Chemoradiation Resistance$160,812
K08 · FY2024 · DE · contact PI
Employing Novel Primary Mouse Models of Head and Neck Cancer to Overcome Chemoradiation Resistance$160,812
K08 · FY2023 · DE · contact PI
Employing Novel Primary Mouse Models of Head and Neck Cancer to Overcome Chemoradiation Resistance$160,812
K08 · FY2022 · DE · contact PI
Employing Novel Primary Mouse Models of Head and Neck Cancer to Overcome Chemoradiation Resistance$160,812
K08 · FY2021 · DE · contact PI
Employing Novel Primary Mouse Models of Head and Neck Cancer to Overcome Chemoradiation Resistance$160,812
K08 · FY2020 · DE · contact PI